Jim Cramer, host of Mad Money, recently pointed out some unexpected trends in the stock market this year, spotlighting a ...

We recently compiled a list of the Jim Cramer Discusses These 9 Stocks & US AI GPU Advantages. In this article, we are going ...

We recently compiled a list of the 12 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...

Author, hedge fund manager, and television personality Jim Cramer is a popular name in the investing sector. He is well known ...

A Treasury union president representing 150,000 federal workers urges them not to accept the Trump administration's buyouts ...

We recently published a list of Jim Cramer Discussed 10 Stocks Leading the Dow Higher in 2025. In this article, we are going ...

Jim Cramer and Katherine Ross are discussing Bernstein's note on Boeing, the second chance market, reopening the economy and Pfizer. "Which is why these numbers were so shockingly bad. Making it ...

CNBC's Jim Cramer reviewed recent market action as earnings season stretches on, telling investors how to spot unwarranted declines in stocks that lead to solid buying opportunities. "This market has ...

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.”  He added, “I can't believe the stock dropped so much.” ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

We recently compiled a list of the Jim Cramer Shed Light on These 8 Stocks Recently. In this article, we are going to take a ...

Cramer says that he's keeping an eye on Pfizer. "I'm more inclined to buy Pfizer, Pfizer offloads these low multiples, these low a low margin drugs and Pfizer's down. That's wrong," said Cramer.